Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Neurotech International Ltd. (AU:NTI)
ASX:NTI
NTI Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.04 - AU$0.13
Previous CloseN/A
Volume11.09K
Average Volume (3M)433.45K
Market Cap
AU$44.81M
Enterprise ValueAU$52.64M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.92
Next Earnings
Mar 04, 2025EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,042,122,000
10 Day Avg. Volume166,783
30 Day Avg. Volume433,449
Standard Deviation0.30
R-Squared0.14
Alpha0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)928.85
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Neurotech International Ltd. News
PremiumCompany Announcements
Neurotech International Appoints New CEO with Incentive Plan
PremiumCompany Announcements
Neurotech Bolsters Cash Position with $2.44 Million R&D Tax Incentive Refund
PremiumCompany Announcements
Neurotech Advances NTI164 Clinical Trials Amid Regulatory Developments
PremiumCompany Announcements
Neurotech International to Expire Listed Options in January
PremiumCompany Announcements
Neurotech International Gains Substantial Investment Stake
PremiumCompany Announcements
Neurotech Director Increases Shareholding in CompanyPremiumCompany Announcements
Neurotech Secures FDA Orphan Drug Status Boost---
Options Prices
Currently, No data available
---
Ownership Overview
NTI FAQ
What was Neurotech International Ltd.’s price range in the past 12 months?
Neurotech International Ltd. lowest share price was AU$0.04 and its highest was AU$0.13 in the past 12 months.
What is Neurotech International Ltd.’s market cap?
Neurotech International Ltd.’s market cap is AU$44.81M.
When is Neurotech International Ltd.’s upcoming earnings report date?
Neurotech International Ltd.’s upcoming earnings report date is Mar 04, 2025 which is in 11 days.
How were Neurotech International Ltd.’s earnings last quarter?
Neurotech International Ltd. released its earnings results on Aug 28, 2024. The company reported -AU$0.004 earnings per share for the quarter, the consensus estimate of -AU$0.004 by AU$0.
Is Neurotech International Ltd. overvalued?
According to Wall Street analysts Neurotech International Ltd.’s price is currently Overvalued.
Does Neurotech International Ltd. pay dividends?
Neurotech International Ltd. does not currently pay dividends.
What is Neurotech International Ltd.’s EPS estimate?
Neurotech International Ltd.’s EPS estimate is >-0.01.
How many shares outstanding does Neurotech International Ltd. have?
Neurotech International Ltd. has 1,042,122,000 shares outstanding.
What happened to Neurotech International Ltd.’s price movement after its last earnings report?
Neurotech International Ltd. reported an EPS of -AU$0.004 in its last earnings report, expectations of -AU$0.004. Following the earnings report the stock price went up 14.286%.
Which hedge fund is a major shareholder of Neurotech International Ltd.?
Currently, no hedge funds are holding shares in AU:NTI
---
Neurotech International Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:NTI Sentiment 76%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth AU$13.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.00%
12-Months-Change
Fundamentals
Return on Equity
-63.92%
Trailing 12-Months
Asset Growth
130.06%
Trailing 12-Months
Company Description
Neurotech International Ltd.
Neurotech International Ltd is a medical device and solutions company. It researches, designs, markets and produces wearable neurotechnology devices to assist with neurological conditions such as autism. Geographically, all the business activity of the firm is functioned through the region of Australia.
---
Technical Analysis
Cann Group Ltd.
―
Invex Therapeutics Ltd.
―
Althea Group Holdings Ltd.
―
Botanix Pharmaceuticals Limited
―
---